Literature DB >> 1534074

Modulation of expression of delayed hypersensitivity by mycobacterial antigen 85 fibronectin-binding proteins.

H P Godfrey1, Z Feng, S Mandy, K Mandy, K Huygen, J De Bruyn, C Abou-Zeid, H G Wiker, S Nagai, H Tasaka.   

Abstract

Although demonstration of delayed hypersensitivity to purified protein derivative of tuberculin (PPD) is an important element in the diagnosis of infection with Mycobacterium tuberculosis, many patients with tuberculosis are anergic. Several possible mechanisms for this specific lack of response have been described. We have now uncovered an additional one. T-cell fibronectin (FN), a lymphokine secreted by activated T cells, is closely associated with the initiation of delayed hypersensitivity reactions. Mycobacterial antigen 85 (Ag85) proteins have been shown to bind to plasma FN. The ability of Ag85 to bind to T-cell FN and modulate expression of delayed hypersensitivity was therefore studied. Purified Ag85 proteins from M. tuberculosis, Mycobacterium bovis BCG, or Mycobacterium kansasii bound to T-cell FN, fibroblast FN, and plasma FN in vitro. Purified 65-kDa heat shock protein (hsp65) from M. bovis BCG did not bind to any FN. Ag85, but not hsp65, inhibited the ability of T-cell FN to agglutinate monocytes in vitro in a dose-dependent manner. In vivo, mixtures of PPD or dinitrophenyl-ovalbumin and purified M. tuberculosis or M. bovis BCG Ag85 proteins elicited significantly smaller delayed hypersensitivity inflammatory reactions in sensitized guinea pigs than did PPD or dinitrophenyl-ovalbumin alone. Purified hsp65 did not inhibit expression of delayed hypersensitivity to PPD or dinitrophenyl-ovalbumin. We suggest that Ag85 proteins could inhibit in vivo expression of delayed hypersensitivity during mycobacterial infections because of their interaction with T-cell FN.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534074      PMCID: PMC257191          DOI: 10.1128/iai.60.6.2522-2528.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis.

Authors:  P Andersen; D Askgaard; L Ljungqvist; M W Bentzon; I Heron
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

2.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

Authors:  P Salgame; J S Abrams; C Clayberger; H Goldstein; J Convit; R L Modlin; B R Bloom
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

3.  Histopathology of delayed-onset hypersensitivities in contact-sensitive guinea pigs.

Authors:  H P Godfrey; M E Phillips; P W Askenase
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

4.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

5.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

6.  T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.

Authors:  P Launois; K Huygen; J De Bruyn; M N'Diaye; B Diouf; L Sarthouj; J Grimaud; J Millan
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

7.  Role of monocyte fucose-receptors in T-cell fibronectin activity.

Authors:  J Donson; K Mandy; Z H Feng; S Mandy; E J Brown; H P Godfrey
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

8.  Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis.

Authors:  S Nagai; H G Wiker; M Harboe; M Kinomoto
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Human immune response to Mycobacterium tuberculosis antigens.

Authors:  D V Havlir; R S Wallis; W H Boom; T M Daniel; K Chervenak; J J Ellner
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Limited clonal heterogeneity of antigen-specific T cells localizing in the pleural space during mycobacterial infection.

Authors:  F Manca; G Rossi; M T Valle; S Lantero; G Li Pira; D Fenoglio; J De Bruin; M Costantini; G Damiani; B Balbi
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

View more
  9 in total

1.  Purification of Mycobacterium bovis BCG Tokyo antigens by chromatofocusing, lectin-affinity chromatography, and hydrophobic interaction chromatography.

Authors:  E A Sugden; K Stilwell; D C Watson; E B Rohonczy; P Martineau
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

2.  Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis.

Authors:  C P Landowski; H P Godfrey; S I Bentley-Hibbert; X Liu; Z Huang; R Sepulveda; K Huygen; M L Gennaro; F H Moy; S A Lesley; M Haak-Frendscho
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection.

Authors:  M Naito; T Fukuda; K Sekiguchi; T Yamada
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

4.  Inhibition of expression of delayed hypersensitivity by neutralizing monoclonal anti-T-cell fibronectin antibody.

Authors:  S Mandy; Z Feng; L S Canfield; K Mandy; X Quan; R A Rowehl; M Y Khan; S K Akiyama; H P Godfrey
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

5.  Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis.

Authors:  T Oettinger; A Holm; I M Mtoni; A B Andersen; K Hasløov
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Mechanism of interaction of the 85B secreted protein of Mycobacterium bovis with fibronectin.

Authors:  P Peake; A Gooley; W J Britton
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Purification of a mycobacterial adhesin for fibronectin.

Authors:  T L Ratliff; R McCarthy; W B Telle; E J Brown
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 8.  The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.

Authors:  H G Wiker; M Harboe
Journal:  Microbiol Rev       Date:  1992-12

9.  Pathophysiology of antigen 85 in patients with active tuberculosis: antigen 85 circulates as complexes with fibronectin and immunoglobulin G.

Authors:  S I Bentley-Hibbert; X Quan; T Newman; K Huygen; H P Godfrey
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.